PATRICK O'CONNELL: Open Payments
NPI 1548899016 · NOVI, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,331 in 102 payments from 14 companies in 2025. Trend: 2023 $47 · 2024 $889 · 2025 $2,331
Food & beverage: $2,331
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $434 |
| Vanda Pharmaceuticals Inc. | 15 | $384 |
| Lundbeck LLC | 10 | $240 |
| Janssen Pharmaceuticals, Inc | 13 | $217 |
| Teva Pharmaceuticals USA, Inc. | 8 | $206 |
| Alkermes, Inc. | 8 | $206 |
| ABBVIE INC. | 7 | $157 |
| Otsuka America Pharmaceutical, Inc. | 5 | $119 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $109 |
| E.R. Squibb & Sons, L.L.C. | 3 | $70 |
Products named: CAPLYTA, FANAPT, REXULTI, SPRAVATO, AUSTEDO XR, ARISTADA, VRAYLAR, TRINTELLIX.
Industry payments across MI — which companies pay providers there.
